Recursion Pharmaceuticals
RXRX
#4281
Rank
NZ$3.40 B
Marketcap
$11.89
Share price
2.45%
Change (1 day)
34.39%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$2.27

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.31. In 2022 the company made an earnings per share (EPS) of -$2.29 a decrease over its 2021 EPS that were of -$1.95.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.27-1.2%
2022-$2.2917.39%
2021-$1.9550.85%
2020-$1.30